The DUSP6-RSK1 pathway: a driver of disease progression in MPNs



Published
Stephen Oh, MD, PhD, Washington University School of Medicine, St. Louis, MO, discusses the promise of targeting the DUSP6-RSK1 pathway in myeloproliferative neoplasms (MPNs), which has shown to be a driver of disease progression. This interview took place at the third annual Texas MPN Workshop (TMW) 2022, held in San Antonio, TX.
Category
Health
Be the first to comment